Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04141 (
granulocyte-macrophage colony-stimulating factor
)
6,790
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
AMSH, a molecule that associates with STAM1, is involved in the in vitro cell growth signaling mediated by interleukin 2 and
granulocyte-macrophage colony-stimulating factor
. To investigate the in vivo functional role of AMSH, we have generated AMSH-deficient mice by gene targeting. The AMSH-deficient mice were morphologically indistinguishable from their littermates at birth, and histopathological examinations revealed normal morphogenesis in all tissues tested. However, all the AMSH-deficient mice exhibited postnatal growth retardation and died between postnatal day 19 (P19) and P23. Examination of brain sections at P6 demonstrated significant loss of neurons and apoptotic cells in the CA1 subfield of the hippocampus.
Brain atrophy
developed by P16 and was accompanied by complete loss of the CA1 neurons in the hippocampus and marked atrophy of the cerebral cortex. Furthermore, AMSH-deficient hippocampal neuronal cells were unable to survive in vitro, even in the presence of several stimulatory cytokines, while AMSH-deficient cerebellar neurons, thymocytes, and embryonic fibroblasts survived normally. Taken together, these observations indicate that AMSH is an essential molecule for the survival of neuronal cells in early postnatal mice.
...
PMID:Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice. 1171 95
Traumatic brain injury (TBI) is an international health concern with a complex pathogenesis resulting in major long-term neurological, neurocognitive, and neuropsychiatric outcomes. Although neuroinflammation has been identified as an important pathophysiological process resulting from TBI, the function of specific inflammatory mediators in the aftermath of TBI remains poorly understood.
Granulocyte-macrophage colony-stimulating factor
(
GM-CSF
) is an inflammatory cytokine that has been reported to have neuroprotective effects in various animal models of neurodegenerative disease that share pathological similarities with TBI. The importance of
GM-CSF
in TBI has yet to be studied, however. We examined the role of
GM-CSF
in TBI by comparing the effects of a lateral fluid percussion (LFP) injury or sham injury in
GM-CSF
gene deficient (
GM-CSF
(-/-)) versus wild-type (WT) mice. After a 3-month recovery interval, mice were assessed using neuroimaging and behavioral outcomes. All mice given a LFP injury displayed significant
brain atrophy
and behavioral impairments compared with those given sham-injuries; however, this was significantly worse in the
GM-CSF
(-/-) mice compared with the WT mice.
GM-CSF
(-/-) mice given LFP injury also had reduced astrogliosis compared with their WT counterparts. These novel findings indicate that the inflammatory mediator,
GM-CSF
, may have significant protective properties in the chronic sequelae of experimental TBI and suggest that further research investigating
GM-CSF
and its potential benefits in the injured brain is warranted.
...
PMID:Granulocyte-macrophage colony-stimulating factor is neuroprotective in experimental traumatic brain injury. 2439 32